MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6701-6710 Newer>
The Motley Fool
September 21, 2010
Brian Orelli
An Acquisition Helps Boston Scientific Breathe Easier Boston Scientific diversifies by picking up device maker Asthmatx. mark for My Articles 128 similar articles
The Motley Fool
September 20, 2010
Brian Orelli
Potential Blockbuster, No Me-Too About It A diabetes-fighting duo do it right this time. mark for My Articles 370 similar articles
The Motley Fool
September 20, 2010
Seth Jayson
How Is CareFusion's Performance at the Margin? Here's the current margin snapshot for CareFusion and some of its sector and industry peers and direct competitors. mark for My Articles 859 similar articles
The Motley Fool
September 20, 2010
Anders Bylund
This Moat Just Keeps Growing! After carving its way into our hearts and portfolios, Intuitive Surgical is still exploring many new fields. mark for My Articles 145 similar articles
The Motley Fool
September 17, 2010
Luke Timmerman
Cell Therapeutics OK'd to Sell Shares to Stay Alive Is the company being straight with shareholders? mark for My Articles 1028 similar articles
Chemistry World
September 17, 2010
Andrew Turley
Free trade could throttle generics from India International agreements on intellectual property threaten the flow of generic HIV drugs from India to developing countries, according to a new report. mark for My Articles 618 similar articles
Chemistry World
September 17, 2010
Andrew Turley
Obesity drugs strive for US approval Could 2010 yet be the year of the obesity drug? At first glance the signs are promising. Regulators in the US will soon decide whether to allow three new contenders onto this attractive market. mark for My Articles 215 similar articles
The Motley Fool
September 17, 2010
Brian Orelli
Thanks for Nothing, Fen-Phen Arena gets knocked down despite a relatively clean side-effect profile. mark for My Articles 246 similar articles
The Motley Fool
September 17, 2010
James Early
Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care. mark for My Articles 369 similar articles
BusinessWeek
September 16, 2010
Olga Kharif
Innovator: Andrew Thompson The engineer-turned-venture capitalist wants to transform your pills into miniature computers that can send out an alert when you miss a dose mark for My Articles 9 similar articles
<Older 6701-6710 Newer>    Return to current articles.